| TRANSMEDICS GROUP |
| USA |
| Gesundheit |
| US89377M1099 / A2PH5P |
| 8T8 (Frankfurt) / TMDX (NASDAQ) |
| FRA:8T8, ETR:8T8, 8T8:GR, NASDAQ:TMDX |
| - |
| https://www.transmedics.c.. |
|
TransMedics Group Inc. is a commercial-stage medical technology company focused on advancing organ transplant therapy for patients with end-stage organ failure. It develops and commercializes the Organ Care System (OCS), a portable platform that pres..
>Volltext.. |
| 2947.62 Mio. EUR |
| 2973.97 Mio. EUR |
| 516.61 Mio. EUR |
| 115.84 Mio. EUR |
| 162.36 Mio. EUR |
| 4.76 EUR |
| 443.05 Mio. EUR |
| 416.68 Mio. EUR |
| 164.53 Mio. EUR |
| 5.47 |
| 20.87% |
| 372.94% |
| - |
| - |
| - |
| - |
| TRANSMEDICS |
| 06.05.26 |
|
||||
|